DRKS00007999
Completed
Not Applicable
Retrospective analysis of treatment with intravitreal injections in patients with AMD, DME and RVO in clinical practice
niversitäts-Augenklinik Freiburg0 sites1,269 target enrollmentApril 8, 2015
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- H35.3
- Sponsor
- niversitäts-Augenklinik Freiburg
- Enrollment
- 1269
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients receiving intravitreal injections of anti\-VEGF for AMD, DME, or RVO
- •patients who were monitored in our IVOM\-outpatients clinic and who received their first injection at least 12 months ago
- •informed consent
Exclusion Criteria
- •VA\-limiting ocular comorbidity (such as other maculopathies, advanced or uncontrolled glaucoma). Vitrectomy in patient history in study eye. VA\-relevant surgery during study (such as cataract surgery).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa.Retinitis Pigmetosa.MedDRA version: 19.0 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Body processes [G] - Genetic Phenomena [G05]EUCTR2016-002523-28-GBMoorfields Eye Hospital1
Completed
Not Applicable
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40
Completed
Not Applicable
Evaluation of the efficacy and safety of intravitreal bimonthly injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000010312Department of Ophthalmology, Shiga University of Medical Science40
Completed
Not Applicable
Analysis of routine data of therapy with intravenous opioid PCA for the relief of dyspnea in palliative care patientsR06.0DyspnoeaDRKS00004232Interdisziplinäres Zentrum für PalliativmedizinUniversitätsklinikum Düsseldorf22
Completed
Phase 2
The Efficacy and Safety of Treatment with Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion.Macula oedema secondary to Branch Retinal Vein Occlusion.Eye - Diseases / disorders of the eyeACTRN12607000262404Associate Professor Ian McAllister40